Autism spectrum disorder (ASD) affects the way a person communicates and interacts with others and influences how they engage with the world around them and how they behave throughout their life. The number of people diagnosed with ASD is rising steadily across the world. In response to the increasing prevalence of the condition and families’ growing dissatisfaction with traditional behavioral therapies, demand for better therapies is growing. This review describes the potential of regenerative medicine and the underlying complex pathophysiology of the condition. ASD is unique in that no two people present identical biological and behavioral characteristics, therefore the greatest challenge in developing effective therapies for ASD is the personalization of medicine. It is widely accepted that the greatest opportunity to influence positive change is young children due to their high levels of neuroplasticity. In particular, Stem Cell IV Therapy Bangkok Thailand is gaining interest as a novel stem cell treatment for ASD within Southeast Asia that may enable direct biological change and repair, as opposed to typical therapies that aim to only manage and control behaviors.
Current medical therapies and interventions focus on training and repairing behaviors and providing pharmacological therapy to manage symptoms, contrasting with the regenerative goals of a stem cell treatment for ASD. Many medical practitioners prescribe atypical antipsychotics or selective serotonin reuptake inhibitors to address secondary symptoms of hyperactivity, aggression, or severe anxiety. It should be noted that these pharmacological agents focus primarily on symptoms of poorly functioning behavioral systems, leaving core neurological systems unchanged. Of greater concern is that these medications frequently cause a range of adverse effects including severe long term weight gain, lethargy, and other debilitating metabolic symptoms, prompting families to explore options like Stem Cell IV Therapy Bangkok Thailand.
They do not address the atypical neural connectivity or chronic neuroinflammation characteristic to the disorder, a limitation that a stem cell treatment for ASD aims to overcome. This gap in FDA approved medications forces a complete restructuring of the field of pediatric neurology in order to address the most severe deficits of the spectrum of disorders. The extreme challenges of traditional methods of treatment and care have directed the global scientific community towards novel biological dimensions, making approaches such as Stem Cell IV Therapy Bangkok Thailand increasingly relevant.
Recent clinical trials evaluating stem cell treatment for ASD have suggested the presence of significant benefits of the application of umbilical cord derived mesenchymal stem cells. One particular case study of a child who received Wharton’s jelly mesenchymal stem cell therapy noted the child’s improvement in gross motor skill and expressive language with the administration of six infusions. There was a significant decrease in severity of the child’s disorder as measured by the Childhood Autism Rating Scale with no significant adverse effects during a follow up period of two years. The Clinical Global Impression also noted significant improvement of the child. There was an increase in the power of the alpha waves on an EEG, reflective of an improvement in social communication, in other similar clinical studies. One review of clinical studies noted umbilical cord blood cells improve social engagement and exploration by modulating the immune system. Transplantation of therapeutic cells in mice with neurodevelopmental disorders caused by the administration of Valproic Acid resulted in significant improvement of the mice’s cognitive function. The administration of bone marrow mononuclear cells in to the CSF resulted in a significant increase in the length of time the subjects maintained eye contact and inattention and a significant decrease in the frequency of behaviors, further supporting the scientific foundation of Stem Cell IV Therapy Bangkok Thailand.
The therapeutic potential of a stem cell treatment for ASD, particularly in specialized hubs offering Stem Cell IV Therapy Bangkok Thailand, is the result of the complex actions of their many bioactive molecules. As highlighted in this review, the pathogenesis of this neurodevelopmental disorder is associated with profound immune dysregulation with increased levels of pro-inflammatory cytokines such as tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6. After transplant, these cells move to damaged areas of the nervous system and secrete interleukin-10. This cytokine has the ability to reprogram the polarization of macrophages and decrease neuroinflammation. Patients with this disorder display an impairment of the inhibitory component of the nervous system due to a marked decrease in gamma-aminobutyric acid interneurons, resulting in an excessive excitatory state in the prefrontal cortex. Mesenchymal cells have the ability to bind and activate tropomyosin receptor kinase B to promote hippocampal neurogenesis and the enhancement of synaptic plasticity and neuroinflammatory processes. Furthermore, the enhancement of neuronal homeostasis and the mitigation of neuroinflammatory processes requires the attenuation of oxidative injury. Hematopoietic cell transplantation is capable of restoring the functionality of superoxide dismutase 2 by modifying the genetic clock. In addition, exosomes from adipose tissue improve neurogenesis. Long non-coding RNAs IFNG-AS1 and their microRNA networks, which are also contained in these exosomes, promote structural repair of the nervous system, revealing the exact mechanisms utilized in a stem cell treatment for ASD such as Stem Cell IV Therapy Bangkok Thailand.
Figure 1: Advanced ASD care in Bangkok
Stem cells demonstrate the ability to provide a multi-faceted biological solution for Autism Spectrum Disorder (ASD) through the potential to repair disrupted neural circuits, making a stem cell treatment for ASD a highly promising avenue. Implementing such therapies, like Stem Cell IV Therapy Bangkok Thailand, can provide a biological solution for the permanent effects of ASD on the developing brain. It can work to repair not only the neural circuits responsible for communication and social engagement, but also the emotional and executive circuits of the brain.
As the demand for an effective stem cell treatment for ASD grows, Thailand has placed itself among the top countries in the world to receive patients for medical tourism, combined with high-end biotechnology like Stem Cell IV Therapy Bangkok Thailand. Thailand has all the infrastructure and skills to run regenerative clinical trials. Thai laboratories have high-end equipment like the Nikon confocal microscope and LC-MS in a clean environment. All researchers will undergo the Research Integrity training provided by the National Research Council of Thailand, which will ensure that all Biomedical and Clinical Research follow international ethical standards.